Back to search

Article

A predictive assay for chemotherapeutic efficacy of stage IV colorectal cancer using serum metabolic features profiling

2024-03-19

Abstract excerpt

<h4>Background: </h4> Currently, there is no unbiased colorectal cancer (CRC) prognostic and predictive model based on serum molecular biomarkers to evaluate potential treatment outcomes and risk of CRC relapse for stage IV CRC patients. In addition, criteria to identify likely CRC patient populations at high risk and might benefit from additional chemotherapeutics have not yet been investigated, and it is an unme...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
76a6d8dc-7fdc-5b6f-b0f0-6f83603213e8
DOI
10.21203/rs.3.rs-4104167/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A predictive assay for chemotherapeutic efficacy of stage IV colorectal cancer using serum metabolic features profilingDOI 10.21203/rs.3.rs-4104167/v1
Select a neighboring publication to make it the new centre.